Soligenix Financial Health

Short Term Liabilities: SNGX's short term assets ($17.5M) exceed its short term liabilities ($9.7M).

Long Term Liabilities: SNGX's short term assets ($17.5M) exceed its long term liabilities ($7.2M).

Debt Level: SNGX has more cash than its total debt.

Reducing Debt: SNGX's debt to equity ratio has increased from 0% to 958.1% over the past 5 years.

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: SNGX has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: SNGX has sufficient cash runway for 1.3 years if free cash flow continues to reduce at historical rates of 16.1% each year.

• Healthy companies in the Pharmaceuticals & Biotech industry.